CANCER TREATMENT REVIEWS, 0305-7372

Journal

Related Publications
  1. Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities

    de Vries, G., Rosas-Plaza, X., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 1-Aug-2020, In : CANCER TREATMENT REVIEWS. 88, 12 p., 102054.

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?

    Knapen, D. G., de Groot, D. J. A., Kwee, T. C., Meijne, E. I. M., Fehrmann, R. S. N. & de Vries, E. G. E., Jul-2020, In : CANCER TREATMENT REVIEWS. 87, 4 p., 102027.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Current management of stage IV nasopharyngeal carcinoma without distant metastasis

    Ng, W. T., Corry, J., Langendijk, J. A., Lee, A. W. M., Mäkitie, A., Mendenhall, W. M., Rinaldo, A., Rodrigo, J. P., Saba, N. F., Smee, R., Strojan, P., Suárez, C., Vermorken, J. B. & Ferlito, A., Apr-2020, In : CANCER TREATMENT REVIEWS. 85, 10 p., 101995.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma

    Veldman, J., Visser, L., Berg, A. V. D. & Diepstra, A., Jan-2020, In : CANCER TREATMENT REVIEWS. 82, 9 p., 101931.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores

    Broekman, K. E., Jalving, M., van Tinteren, H., Sessa, C. & Reyners, A. K. L., Sep-2018, In : CANCER TREATMENT REVIEWS. 69, p. 233-242 10 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (52) »

ID: 2006534